According to a new report, published by KBV research, The Global Pediatric Perfusion Market size is expected to reach $801.8 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period.
The Hospitals segment is generating the highest revenue in the Global Pediatric Perfusion Market by End-use in 2022; thereby, achieving a market value of $601.3 million by 2030. The market is growing because of the increasing number of people with heart and lung conditions, as well as the increasing number of organ transplant procedures performed in hospitals. For example, Stanford Medicine Children's Health's "2022 Transplant Outcomes Report" states that the hospital performed more than 500 pediatric heart transplants, 680 pediatric kidney transplants, 832 pediatric liver and intestinal transplants, and more than 85 pediatric lung and heart-lung transplants.
The Pediatric Cannulae segment is experiencing a CAGR of 6.3% during (2023 - 2030). Pediatric cannulae, devices used to access and return blood during cardiac and vascular procedures in children, offer several benefits in pediatric cardiac care. The size and flexibility of pediatric cannulae reduces the risk of vascular trauma, making them ideal for use in children with delicate vascular systems. This lowers the chances of complications during and after procedures. Hemolysis, the rupture of red blood cells, can occur when blood is exposed to excessive shear forces or turbulence.
The North America region dominated the Global Pediatric Perfusion Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $316.1 million by 2030. The Europe market is anticipated to grow a CAGR of 5.6% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 6.6% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/pediatric-perfusion-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
By End Use
By Product
By Geography
Companies Profiled
Unique Offerings 
